A PROMISE FOR A HEALTHIER TOMORROW

Ciprotak-XL500 &1000 mgF.C.Tablets

Ciprotak-XL
Ciprotak-XL
An extended release formulation ensuring continuous release of Ciprofloxacin for 24 hours with high tolerability and safety profiles.
Composition:

Each film coated tablet contains: Ciprofloxacin  base 500 mg & 1000 mg. 

Propertise:

Ciprotak-XL: exerts its action through the inhibition of bacterial DNA gyrase (topoisomerase II) & inhibition of bacterial topoisomerase IV with the formation of quinolone DNA gyrase complex which consequently induces DNA cleavage and inhibition of protein synthesis.

Ciprotak-XL: is an extended release formulation, it ensures continuous release of ciprofloxacin  for 24 hours.

Ciprotak-XL: is highly tolerable, it shows 43% reduction in its gastrointestinal adverse effects than the conventional cipro?oxacin.

Ciprotak-XL: may be administered with or without food. 

Indications:

• Uncomplicated & complicated urinary tract infections.

• Acute uncomplicated pyelonephritis. 

Dosage & Administration:

• For uncomplicated UTI: one tablet of Ciprotak-XL 500 mg once daily for 3 days.

• For complicated UTI & acute uncomplicated pyelonephritis: one tablet of Ciprotak-XL 1gm once daily for 7-14 days.